A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort as Maintenance and Relief Therapy in a Single Inhaler (Symbicort SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed).
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2009
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 Jul 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 10 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2007 New trial record.